Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
Clinical trial NCT02648282 · COMPLETED
Trial details
- NCT number
- NCT02648282
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2022-06-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.